± HEALTH In our modern society, digital devices, social media platforms, and artificial intelligence (AI) tools have b…+ CLIMATE The growing complexity of electric vehicle charging station (EVCS) operations—driven by grid constraints, ren…± HEALTH Objectives This study aim to develop, compare and internally validate machine-learning models for predicting…+ HEALTH Diabetes management faces a number of obstacles, such as fragmented healthcare data, privacy concerns, poor e…− SCIENCE Background Craniofacial soft tissue thickness (CFSTT) is a critical parameter in forensic facial reconstructi…+ HEALTH Background Technological innovation in total joint arthroplasty (TJA) has largely focused on intraoperative p…± HEALTH Infective endocarditis (IE) continues to be an often fatal condition despite improvements in cardiac surgical…± HEALTH Purpose of review Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is the leading cause of d…
TruaceTracing the truth around AIFriday, September 11, 2026
Subscribe
Health·The Trace·Dual reading·Published 2026-09-10

supervised ML models predicting all-cause mortality in adult infective endocarditis patients

Source article: Machine Learning for Mortality Prediction in Infective Endocarditis: A Systematic Review and Meta-Analysis

Abstract: Infective endocarditis (IE) continues to be an often fatal condition despite improvements in cardiac surgical procedures and antibiotic therapy, and conventional scoring tools show poor generalizability. Machine learning (ML) addresses these limitations by capturing complex, nonlinear clinical relationships, outperforming conventional scores in predictive accuracy, though prior ML work in IE has focused on diagnosis. A PRISMA-compliant systematic review and meta-analysis of PubMed (Supplemental Digital Content,…

TRV-2026-1049Peer-reviewedPermanent record — cite & verify
Trace impact reading

Contested: both sides are scored from claims and sources, not community votes.

P 73The P score combines the specificity and measured human impact of the grounded problem claim with the strength of this Trace’s cited sources.G 69The G score combines the specificity and measured human impact of the grounded gain claim with the strength of this Trace’s cited sources.
Machine Learning for Mortality Prediction in Infective Endocarditis: A Systematic Review and Meta-Analysis

Cardio Surgery 1 by Dominique Cappronnier. CC BY-SA 3.0 · https://creativecommons.org/licenses/by-sa/3.0

The quick read

A PRISMA-compliant systematic review and meta-analysis of 8 studies with 5503 adult patients evaluated supervised machine learning models to predict all-cause mortality in infective endocarditis, a condition described as often fatal despite surgical and antibiotic advances. Five studies were pooled, showing strong discrimination for both in-hospital/early and 6-month mortality.

The findings matter because conventional scoring tools show poor generalizability, while ML ensemble approaches captured complex nonlinear relationships and outperformed them. Uncertainty remains due to predominantly retrospective data, identified bias in 4 studies, and limited bedside adoption, with authors calling for multicenter prospective validation and interpretable frameworks.

Main points
  • Systematic review included 8 studies with 5503 adult IE patients, mean age 53.85, with 5 studies pooled for AUC.
  • Seven studies were retrospective and 1 was prospective, with quality appraised using PROBAST and TRIPOD.
  • Dominant predictor domains varied: multisystem physiologic markers in general cohorts, dynamic and laboratory variables in ICU, procedural and anatomical factors in surgical and TAVR models.
Gain

Supervised ML models, especially ensemble methods, predicted all-cause mortality in adult infective endocarditis with pooled AUC 0.85 for both in-hospital/early and 6-month mortality, outperforming conventional scores.

Problem

Half of included studies had identified risk of bias and clinical adoption remains limited, requiring multicenter prospective validation and interpretable frameworks before bedside use.

The rundown

The review searched PubMed and Scopus through April 2026 under PRISMA, including adult IE cohorts with supervised ML predicting all-cause mortality. Five studies contributed AUC or C-index estimates pooled via random-effects models stratified into in-hospital/early and 6-month mortality subgroups.

Authors reported I2 of 35.3% for in-hospital/early mortality and 0% for 6-month mortality, and noted that ensemble methods captured multivariate heterogeneity better than conventional tools that show poor generalizability.

What this doesn’t fix

Evidence base is limited by retrospective design and bias, with 7 of 8 studies retrospective and risk of bias in half, requiring prospective multicenter validation before bedside use.

Sources

Reader signal

How should this claim be treated?

The debate